Saturday, December 30, 2017

A high dose of this drug can increase the risk of heart failure in cancer patients

  1. A high dose of this drug can increase the risk of heart failure in cancer patients  TheHealthSite
  2. Carfilzomib can lead to cardiovascular toxicity in multiple myeloma patients  InfosurhoyFull coverage
(CLICK HERE TO READ AND SEE MORE

0 comments:

Post a Comment